Medikit Co Stock

Medikit Co Quick Ratio

The Quick Ratio (Acid Test) of Medikit Co (7749.T) as of Aug 26, 2026 is 4.66. In the previous year, Quick Ratio (Acid Test) was 5.35 — a change of -13.03% (lower).

Quick Ratio

4.66

YoY

-13.03%

Last updated:

Quick Ratio (Acid Test) of Medikit Co is 2026 4.66 . Quick Ratio (Acid Test) of Medikit Co was 2025 5.35 . It decreases by -13.03% lower compared to the previous year.
Access this data via the Eulerpool API

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medikit Co stock

Quick Ratio (Acid Test) of Medikit Co is 4.66 in 2026.

Quick Ratio (Acid Test) of Medikit Co changed from 5.35 to 4.66, representing a -13.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Medikit Co since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Medikit Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Medikit Co

All Key Metrics — Medikit Co